Development of Macrocyclic Peptides as Modulators of G-protein Activity

webinar

Thu, 21 Apr 2022, 16:00 CEST (Berlin)

Prof. Dr. Diana Imhof, University of Bonn, Germany

Development of Macrocyclic Peptides as Modulators of G-protein Activity

Heterotrimeric G-proteins are important components of intracellular signal transduction, since G-proteins transmit information from an externally stimulated, membrane-bound G-protein-coupled receptor (GPCR) into the cell interior. The importance of these signaling cascades cannot be denied: More than 30% of the approved drugs address the extracellularly easily accessible GPCRs. Since the Gα subunit directly interacts with both the GPCR and the effectors, Gα plays a crucial role in GPCR signaling. This is reflected in the fact that signaling specificity is achieved through four distinct Gα subfamilies: Gαs, Gαi, Gαq, and Gα12/13, which mediate distinct signaling pathways in the cell. Considering the influence of G-proteins on (patho)physiological processes, tools to modulate the action of Gα proteins are of great interest for current pharmaceutical research. However, the direct targeting of intracellular Gα subunits by chemical agents still is a great challenge, since the activity of the compound must be combined with cell-penetrating properties.

Diana shall present an approach to combine (“wet”) high-throughput techniques with computational approaches to gain a deeper insight into potential binding sites, that can then be addressed for compound design. She will focus on the development of a first series of linear and cyclic peptides, which turned out to possess a GEM (guanine nucleotide exchange modulator)-like activity concerning the modulation of Gai and Gas proteins — this does provide new opportunities for intracellular targeting of GPCR-dependent signaling pathways.
Join Diana and us and learn about her latest GPCR research.

Current news

category
Events
Announcing BioSolveIT's DrugSpace Symposium 2025: Bridging Science
June 26, 2025 09:43 CEST
We are pleased to announce the fourth edition of the BioSolveIT DrugSpace Symposium, taking place on September 24–25, 2025. This year’s theme, “Bridging Science,” highlights the growing importance of interdisciplinary collaboration in driving innovation across the drug discovery landscape. As the field evolves, it becomes increasingly clear that real progress...
Read on
Psst... Are You Following Us Yet? Follow the Science (and a Bit More)
June 25, 2025 08:44 CEST
There’s a lot going on behind the scenes—ideas taking shape, tools evolving, science in motion. And while the website tells you what our software does, our social media gives you a look at how it lives. We’re active on LinkedIn, BlueSky, and YouTube, sharing everything from scientific snapshots to educational...
Read on
AMBrosia Just Got Bigger: 126 Billion Compound Update Now Available
June 11, 2025 13:21 CEST
We are thrilled to announce a major update to the AMBrosia Chemical Space in collaboration with Ambinter! The state-of-the-art source for diverse drug-like scaffolds now boasts an incredible 126 billion of synthetically accessible compounds for drug discovery projects. What does the update feature? Expanded to an astounding 125,924,571,692 compounds (1.26...
Read on